Drug Trial Radar · NCT00846755
Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening
Last checked: Nov 19, 2026Latest source record: Sep 27, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,657
Actual
Start
Mar 2005
Primary completion
Mar 2008
Study completion Dec 2008
Sponsor
- Lead sponsor
- Ospedale V. FazziAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 19, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether treatment of thyroid disease during pregnancy decrease the incidence of adverse outcome, and to compare the impact of Universal Screening versus case Finding strategy in detecting thyroid dysfunction
Conditions
- Thyroid Disease
- Pregnancy
Interventions
Levothyroxine, PropylthiouracileDrug
Drugs were titrated to render euthyroid pregnant patients with thyroid disease
Primary outcomes
What the sponsor says the trial is designed to measure.
- number of adverse outcomes which occur during pregnancy and in the neonatal period in patients divided in Case Finding and Universal Screening groupsTime frame: 9 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
"V. Fazzi" Hospital
Lecce, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.